查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
寡核苷酸合成市場：趨勢、機會與競爭分析 [2023-2028]
市場調查報告書
商品編碼
1341989

寡核苷酸合成市場：趨勢、機會與競爭分析 [2023-2028]

Oligonucleotide Synthesis Market: Trends, Opportunities and Competitive Analysis [2023-2028]
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

寡核苷酸合成市場趨勢及預測

預計到2028年，全球寡核苷酸合成市場將達到 158 億美元，2023年至2028年年複合成長率為 16.1%。該市場的主要促進因素是增加政府對製藥和生物技術領域的資助和研究投資、增加合成寡核苷酸在分子診斷和臨床應用中的利用率，以及全球癌症和遺傳疾病發病率的增加。全球寡核苷酸合成市場的未來前景廣闊，為醫院、製藥和生物技術公司、診斷實驗室、CRO 和 CMO 以及學術研究機構提供了商機。

寡核苷酸合成市場洞察

  • Lucintel 預測，由於基因組研究(包括基因表現分析和基因測試)的日益普及，以及能夠同時分析各種臨床樣本的生物晶片(DNA 晶片)的出現，寡核苷酸在預測期內將具有最高的成長率。
  • 在這個市場中，已開發國家的大學和學術研究機構與私人投資者共同或在政府支持下對基因組研究進行巨額投資，基因組研究積極開展，學術研究機構仍將是最大的細分市場。
  • 由於慢性病罹患率不斷上升以及該地區有許多公司和研究機構，預計北美在預測期內仍將是最大的地區。

本報告回答了 11 個關鍵問題：

  • Q.1.細分市場中最有前途和高成長的機會為何？
  • Q.2.哪個細分市場將以更快的速度成長？理由為何？
  • Q.3.哪些地區未來會出現更快的成長？理由為何？
  • Q.4.影響市場動態的主要要素有哪些？市場的主要挑戰和商業風險是什麼？
  • Q.5.這個市場的商業風險和競爭威脅為何？
  • Q.6.這個市場有哪些新趨勢？理由為何？
  • Q.7.市場客戶需求有何改變？
  • Q.8.該市場有哪些新發展以及哪些公司處於領先地位？
  • Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
  • Q.10.該市場上的競爭產品有哪些，由於材料或產品替代導致市場佔有率下降的威脅有多大？
  • Q.11.過去年度發生了哪些併購事件，對產業產生了哪些影響？

目錄

第1章 執行摘要

第2章 全球寡核苷酸合成市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2017-2028年市場趨勢及預測分析

  • 宏觀經濟趨勢(2017-2022)與預測(2023-2028)
  • 全球寡核苷酸合成市場趨勢(2017-2022)與預測(2023-2028)
  • 全球寡核苷酸合成市場(依產品)
    • 寡核苷酸
    • 設備/合成器
    • 試劑
    • 服務
    • 精製
  • 全球寡核苷酸合成市場依應用
    • PCR引子
    • PCR 檢測和麵板
    • 順序
    • DNA微陣列
    • 螢光原位雜合技術(FISH)
  • 依最終用途行業分類的全球寡核苷酸合成市場
    • 醫院
    • 製藥和生物技術公司
    • 診斷實驗室
    • CRO和CMO
    • 學術研究所

第4章 2017-2028年分地區市場趨勢及預測分析

  • 全球寡核苷酸合成市場區域分佈
  • 北美寡核苷酸合成市場
  • 歐洲寡核苷酸合成市場
  • 亞太寡核苷酸合成市場
  • 其他區域性寡核苷酸合成市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 全球寡核苷酸合成市場成長機會(依產品)
    • 全球寡核苷酸合成市場成長機會(依應用)
    • 全球寡核苷酸合成市場成長機會(依最終用途產業)
    • 全球寡核苷酸合成市場成長機會(依地區)
  • 全球寡核苷酸合成市場的新趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球寡核苷酸合成市場的產能
    • 全球寡核苷酸合成市場的合併、收購與合資企業
    • 認證和許可

第7章 主要企業概況

  • Thermo Fisher Scientific
  • GE Healthcare
  • Dharmacon
  • Agilent Technologies
  • Bio-synthesis
  • Kaneka Eurogentec
  • Integrated DNA Technologies
  • BioAutomation
  • Biolegio
  • Twist Bioscience
簡介目錄

Oligonucleotide Synthesis Market Trends and Forecast

The future of the global oligonucleotide synthesis market looks promising with opportunities in hospitals, pharmaceutical & biotechnology companies, diagnostic laboratories, CROs and CMOs, and academic research institutes. The global oligonucleotide synthesis market is expected to reach an estimated $15.8 billion by 2028 with a CAGR of 16.1% from 2023 to 2028. The major drivers for this market are increasing government funding and research investments within the pharmaceutical and biotechnology sectors, rising utilization of synthesized oligonucleotides in molecular diagnostics and clinical applications, and rising incidence of cancer and genetic disorders globally.

A more than 150-page report is developed to help in your business decisions.

Oligonucleotide Synthesis Market by Segment

The study includes a forecast for the global oligonucleotide synthesis market by product, application, end use industry, and region, as follows:

Oligonucleotide Synthesis Market by Product [Shipment Analysis by Value from 2017 to 2028]:

  • Oligonucleotides
  • Equipment/Synthesizer
  • Reagents
  • Services
  • Purification
  • Modification

Oligonucleotide Synthesis Market by Application [Shipment Analysis by Value from 2017 to 2028]:

  • PCR Primers
  • PCR Assays and Panels
  • Sequencing
  • DNA Microarrays
  • Fluorescence In Situ Hybridization (FISH)
  • Antisense Oligonucleotides
  • Others

Oligonucleotide Synthesis Market by End Use Industry [Shipment Analysis by Value from 2017 to 2028]:

  • Hospitals
  • Pharmaceutical & Biotechnology Companies
  • Diagnostic Laboratories
  • CROs and CMOs
  • Academic Research Institutes

Oligonucleotide Synthesis Market by Region [Shipment Analysis by Value from 2017 to 2028]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Oligonucleotide Synthesis Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, oligonucleotide synthesis companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the oligonucleotide synthesis companies profiled in this report include:

  • Thermo Fisher Scientific
  • GE Healthcare
  • Dharmacon
  • Agilent Technologies
  • Bio-synthesis
  • Kaneka Eurogentec
  • Integrated DNA Technologies
  • BioAutomation
  • Biolegio
  • Twist Bioscience

Oligonucleotide Synthesis Market Insights

  • Lucintel forecasts that oligonucleotide will witness the highest growth over the forecast period due to the rising prevalence of genomic research endeavors, including gene expression analysis and genetic testing, along with the advent of biochips (DNA chips) enabling simultaneous analysis of various clinical samples.
  • Within this market, academic research institutes will remain the largest segment due to robust genomic research being conducted by universities and academic research institutes either in collaboration with private investors or with government support along with huge investments in the genomic research in developed countries.
  • North America will remain the largest region over the forecast period due to increasing incidence of chronic diseases and the substantial presence of numerous companies and research institutes in this region.

Features of the Global Oligonucleotide Synthesis Market

  • Market Size Estimates: Oligonucleotide synthesis market size estimation in terms of value ($B).
  • Trend and Forecast Analysis: Market trends (2017 to 2022) and forecast (2023 to 2028) by various segments and regions.
  • Segmentation Analysis: Oligonucleotide synthesis market size by various segments, such as by product, application, end use industry, and region in terms of value ($B).
  • Regional Analysis: Oligonucleotide synthesis market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different products, applications, end use industries, and regions for the Oligonucleotide Synthesis Market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the oligonucleotide synthesis market.
  • Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

  • Q.1. What is the oligonucleotide synthesis market size?
  • Answer: The global oligonucleotide synthesis market is expected to reach an estimated $15.8 billion by 2028.
  • Q.2. What is the growth forecast for oligonucleotide synthesis market?
  • Answer: The global oligonucleotide synthesis market is expected to grow with a CAGR of 16.1% from 2023 to 2028.
  • Q.3. What are the major drivers influencing the growth of the oligonucleotide synthesis market?
  • Answer: The major drivers for this market are increasing government funding and research investments within the pharmaceutical and biotechnology sectors, rising utilization of synthesized oligonucleotides in molecular diagnostics and clinical applications, and rising incidence of cancer and genetic disorders globally.
  • Q4. What are the major segments for oligonucleotide synthesis market?
  • Answer: The future of the global oligonucleotide synthesis market looks promising with opportunities in hospitals, pharmaceutical & biotechnology companies, diagnostic laboratories, CROs and CMOs, and academic research institutes.
  • Q5. Who are the key oligonucleotide synthesis companies?
  • Answer: Some of the key oligonucleotide synthesis companies are as follows:
    • Thermo Fisher Scientific
    • GE Healthcare
    • Dharmacon
    • Agilent Technologies
    • Bio-Synthesis
    • Kaneka Eurogentec
    • Integrated DNA Technologies
    • BioAutomation
    • Biolegio
    • Twist Bioscience
  • Q6. Which oligonucleotide synthesis market segment will be the largest in future?
  • Answer: Lucintel forecasts that oligonucleotide will witness the highest growth over the forecast period due to the rising prevalence of genomic research endeavors, including gene expression analysis and genetic testing, along with the advent of biochips (DNA chips) enabling simultaneous analysis of various clinical samples.
  • Q7. In oligonucleotide synthesis market, which region is expected to be the largest in next 5 years?
  • Answer: North America will remain the largest region over the forecast period due to increasing incidence of chronic diseases and the substantial presence of numerous companies and research institutes in this region.
  • Q.8. Do we receive customization in this report?
  • Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the oligonucleotide synthesis market by product (oligonucleotides, equipment/synthesizer, reagents, services, purification, and modification), application (PCR primers, PCR assays and panels, sequencing, DNA microarrays, fluorescence in situ hybridization (FISH), antisense oligonucleotides, and others), end use industry (hospitals, pharmaceutical & biotechnology companies, diagnostic laboratories, CROs and CMOs, and academic research institutes), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last five years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Oligonucleotide Synthesis Market: Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2017 to 2028

  • 3.1: Macroeconomic Trends (2017-2022) and Forecast (2023-2028)
  • 3.2: Global Oligonucleotide Synthesis Market Trends (2017-2022) and Forecast (2023-2028)
  • 3.3: Global Oligonucleotide Synthesis Market by Product
    • 3.3.1: Oligonucleotides
    • 3.3.2: Equipment/Synthesizer
    • 3.3.4: Reagents
    • 3.3.5: Services
    • 3.3.6: Purification
  • 3.4: Global Oligonucleotide Synthesis Market by Application
    • 3.4.1: PCR Primers
    • 3.4.2: PCR Assays and Panels
    • 3.4.3: Sequencing
    • 3.4.4: DNA Microarrays
    • 3.4.5: Fluorescence in Situ Hybridization (FISH)
  • 3.5: Global Oligonucleotide Synthesis Market by End Use Industry
    • 3.5.1: Hospitals
    • 3.5.2: Pharmaceutical & Biotechnology Companies
    • 3.5.3: Diagnostic Laboratories
    • 3.5.4: CROs and CMOs
    • 3.5.5: Academic Research Institutes

4. Market Trends and Forecast Analysis by Region from 2017 to 2028

  • 4.1: Global Oligonucleotide Synthesis Market by Region
  • 4.2: North American Oligonucleotide Synthesis Market
    • 4.2.1: North American Oligonucleotide Synthesis Market by Product: Oligonucleotide, Equipment/Synthesizer, Reagents, Services, Purification, and Modification
    • 4.2.2: North American Oligonucleotide Synthesis Market by End Use Industry: Hospitals, Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, CROs and CMOs, and Academic Research Institutes
  • 4.3: European Oligonucleotide Synthesis Market
    • 4.3.1: European Oligonucleotide Synthesis Market by Product: Oligonucleotide, Equipment/Synthesizer, Reagents, Services, Purification, and Modification
    • 4.3.2: European Oligonucleotide Synthesis Market by End Use Industry: Hospitals, Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, CROs and CMOs, and Academic Research Institutes
  • 4.4: APAC Oligonucleotide Synthesis Market
    • 4.4.1: APAC Oligonucleotide Synthesis Market by Product: Oligonucleotide, Equipment/Synthesizer, Reagents, Services, Purification, and Modification
    • 4.4.2: APAC Oligonucleotide Synthesis Market by End Use Industry: Hospitals, Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, CROs and CMOs, and Academic Research Institutes
  • 4.5: ROW Oligonucleotide Synthesis Market
    • 4.5.1: ROW Oligonucleotide Synthesis Market by Product: Oligonucleotide, Equipment/Synthesizer, Reagents, Services, Purification, and Modification
    • 4.5.2: ROW Oligonucleotide Synthesis Market by End Use Industry: Hospitals, Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, CROs and CMOs, and Academic Research Institutes

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Oligonucleotide Synthesis Market by Product
    • 6.1.2: Growth Opportunities for the Global Oligonucleotide Synthesis Market by Application
    • 6.1.3: Growth Opportunities for the Global Oligonucleotide Synthesis Market by End Use Industry
    • 6.1.4: Growth Opportunities for the Global Oligonucleotide Synthesis Market by Region
  • 6.2: Emerging Trends in the Global Oligonucleotide Synthesis Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Oligonucleotide Synthesis Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Oligonucleotide Synthesis Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Thermo Fisher Scientific
  • 7.2: GE Healthcare
  • 7.3: Dharmacon
  • 7.4: Agilent Technologies
  • 7.5: Bio-synthesis
  • 7.6: Kaneka Eurogentec
  • 7.7: Integrated DNA Technologies
  • 7.8: BioAutomation
  • 7.9: Biolegio
  • 7.10: Twist Bioscience